Jason Hulse Murray, the chief executive officer of $PACS Group, Inc. ($PACS), sold 24,224 shares on October 5, 2026, at $42.6551 per share, for a total of $1,033,277.14. The sale was recorded as an open-market transaction on a Form 4 filed the same day. The filing listed 54,471,941 shares owned after the sale.
The October 5 sale was the fourth open-market sale Murray reported in that single filing. The other three transactions were:
- October 1: 33,032 shares at $41.1255, totaling $1,358,458.
- October 2: 23,456 shares at $42.5931, totaling $999,064.
- October 2: 2,596 shares at $41.7902, totaling $108,487.
Across the four sales, Murray sold 83,308 shares for approximately $3.50 million. The October 1 and October 2 trades were disclosed in the Form 4 filed on October 5, four days and three days after those transactions, respectively.
$PACS Group is a health care company with a market capitalization of roughly $6.78 billion. Other insiders also reported open-market sales during 2026. Director and co-founder Mark Hancock reported six sales in late June and early July totaling about $15.37 million and covering 361,068 shares. Those transactions included 142,163 shares sold on July 6 at $45.3343 for $6,444,860, 138,069 shares on June 25 for $5,567,701, and 61,731 shares on June 26 for $2,499,883; he also sold 12,825 shares on July 2 for $577,290, 6,080 shares on July 1 for $273,716, and 200 shares on June 26 for $8,202. Chief Legal Officer John Todd Mitchell reported sales in May 2026 and November 2025. His filings included 159,556 shares sold on November 24, 2025, for $4,768,379, plus four May 2026 sales: 45,949 shares for $1,742,037 and 6,814 shares for $263,977 on May 15, followed by 24,089 shares for $892,252 and 3,300 shares for $125,441 on May 18. Combined, Mitchell's four May 2026 sales totaled about $3.02 million. COO Joshua Jergensen reported a sale of 36,335 shares on March 13, 2026, at $34.2823 for $1,245,647.
The filings reviewed also included an open-market purchase by Director Evelyn S. Dilsaver, who bought 16,724 shares on November 24, 2025, at $29.897 for $499,997. Taken together, the reviewed filings showed about $27.9 million in open-market sales by $PACS insiders since November 2025, alongside the Dilsaver purchase. The October 5 transaction was reported the same day it took place, while the October 1 sale reached the Form 4 four days after the trade and the October 2 sales three days after. The $42.6551 per-share price on October 5 was the highest of the four transactions in the cluster.